Atrial fibrillation: Difference between revisions
imported>Robert Badgett |
imported>Robert Badgett |
||
| Line 114: | Line 114: | ||
{| class="wikitable" align="right" | {| class="wikitable" align="right" | ||
|+ [[Dabigatran]] versus [[warfarin]] for [[atrial fibrillation]] | |+ [[Dabigatran]] versus [[warfarin]] for [[atrial fibrillation]]<ref name="pmid19717844">{{cite journal| author=Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al.| title=Dabigatran versus Warfarin in Patients with Atrial Fibrillation. | journal=N Engl J Med | year= 2009 | volume= 361 | issue= 12 | pages= 1139-1151 | pmid=19717844 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19717844 | doi=10.1056/NEJMoa0905561 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | |||
! rowspan="2"|Intervention!! colspan="3"|Outcomes | ! rowspan="2"|Intervention!! colspan="3"|Outcomes | ||
|- | |- | ||
Revision as of 11:29, 21 September 2009
Diagnosis
Routine office evaluation
A study of routine pulse checks or electrocardiograms during routine office visits, found that the annual rate of detection of atrial fibrillation in elderly patients improved from 1.04% to 1.63%.[1] This implies that the sensitivity of the routine examination is 64% (1.04/1.63).
Electrocardiogram
Regarding the accuracy of the electrocardiogram[2]:
- Interpreted by software:
- sensitivity = 83%
- specificity = 99%
- Interpreted by a primary care physician:
- sensitivity = 80%
- specificity = 92%
- Interpreted by a primary care physician with software:
- sensitivity = 92%
- specificity = 91%
Prognosis
Risk of stroke
The risk of stroke in a patient with atrial fibrillation can be predicted with the CHADS2 score.
Treatment
Clinical practice guidelines by the American College of Physicians and the American Academy of Family Physicians address treatment.[3][4]
Rate control versus rhythm control
Medications
- "Rate control with chronic anticoagulation is the recommended strategy for the majority of patients with atrial fibrillation. ... Rhythm control is appropriate when based on other special considerations, such as patient symptoms, exercise tolerance, and patient preference."[3]
The goal rate is "80 beats per minute during resting ... and of less than 110 beats per minute during a 6-minute walk test."[5]
As compared to rate control, rhythm control was associated with slight, although statistically insignificant, increase in adverse outcomes in randomized controlled trials.[6][5][7] In addition, "the incidence of the components of the primary end point did not differ significantly according to whether the patient had sinus rhythm or atrial fibrillation at the end of follow-up."[6] Whether the index episode was the initial or a recurrent episode did not effect results.[7]
| Study | Patients | Intervention in rhythm control group | Results | |
|---|---|---|---|---|
| Rhythm control group | Rate control group | |||
| Van Gelder[6] 2002 |
|
|
|
|
| AFFIRM[7] 2002 |
|
|
|
|
| Roy[5] 2008 |
|
|
|
|
- Episodic therapy
Episodic medical therapy has conflicting results with a positive uncontrolled before and after trial of flecainide and propafenone[8] and a negative randomized controlled trial of episodic amiodarone versus continuous amiodarone.[9]
Artificial pacemakers
Regarding artificial pacemakers, "dual-chamber minimal ventricular pacing, as compared with conventional dual-chamber pacing, ...reduces the risk of persistent atrial fibrillation in patients with sinus-node disease" according to a randomized controlled trial.[10]
Dual site, overdrive pacing be effective.[11]
Ablation
Pulmonary-vein isolation
Randomized controlled trial have found that using ablation to cause pulmonary-vein isolation was superior to medical therapy[12][13] and to atrioventricular-node ablation[14].
Anticoagulation
- "Patients with atrial fibrillation should receive chronic anticoagulation with adjusted-dose warfarin, unless they are at low risk of stroke or have a specific contraindication to the use of warfarin (thrombocytopenia, recent trauma or surgery, alcoholism). "[3]
Anticoagulation can prevent recurrent stroke. Among patients with nonvalvular atrial fibrillation, anticoagulation can reduce stroke by 60% while antiplatelet agents can reduce stroke by 20%. [15]. However, a recent meta-analysis suggests harm from anti-coagulation started early after an embolic stroke.[16]
If warfarin is contraindicated, the combination of clopidogrel and aspirin can help, especially be reducing stroke, but increases the risk of major hemorrhage.[17]
In 2009, dabigatran, a direct thrombin inhibitors, was compared to warfarin in the RE-LY randomized controlled trial.[18]
| Intervention | Outcomes | ||
|---|---|---|---|
| Stroke or systemic embolism | Major bleeding | Mortality | |
| Dabigatran 110 mg twice daily | 1.53% | 2.71%† | 3.75% |
| Dabigatran 150 mg twice daily | 1.11%† | 3.11% | 3.64% |
| Warfarin | 1.69% | 3.36% | 4.13% |
| † p < 0.05 as compared to warfarin group | |||
References
- ↑ Fitzmaurice DA, Hobbs FD, Jowett S, et al (2007). "Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial". DOI:10.1136/bmj.39280.660567.55. PMID 17673732. Research Blogging.
- ↑ Mant J, Fitzmaurice DA, Hobbs FD, et al (2007). "Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial". DOI:10.1136/bmj.39227.551713.AE. PMID 17604299. Research Blogging.
- ↑ 3.0 3.1 3.2 Snow V, Weiss KB, LeFevre M, et al (December 2003). "Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians". Ann. Intern. Med. 139 (12): 1009–17. PMID 14678921. [e]
- ↑ McNamara RL, Tamariz LJ, Segal JB, Bass EB (December 2003). "Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography". Ann. Intern. Med. 139 (12): 1018–33. PMID 14678922. [e]
- ↑ 5.0 5.1 5.2 Roy D, Talajic M, Nattel S, et al (June 2008). "Rhythm control versus rate control for atrial fibrillation and heart failure". N. Engl. J. Med. 358 (25): 2667–77. DOI:10.1056/NEJMoa0708789. PMID 18565859. Research Blogging.
- ↑ 6.0 6.1 6.2 Van Gelder IC, Hagens VE, Bosker HA, et al (December 2002). "A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation". N. Engl. J. Med. 347 (23): 1834–40. DOI:10.1056/NEJMoa021375. PMID 12466507. Research Blogging.
- ↑ 7.0 7.1 7.2 Wyse DG, Waldo AL, DiMarco JP, et al (December 2002). "A comparison of rate control and rhythm control in patients with atrial fibrillation". N. Engl. J. Med. 347 (23): 1825–33. DOI:10.1056/NEJMoa021328. PMID 12466506. Research Blogging.
- ↑ Alboni P, Botto GL, Baldi N, et al (December 2004). "Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach". The New England journal of medicine 351 (23): 2384–91. DOI:10.1056/NEJMoa041233. PMID 15575054. Research Blogging.
- ↑ Ahmed, Sheba; Michiel Rienstra, Harry J. G. M. Crijns, Thera P. Links, Ans C. P. Wiesfeld, Hans L. Hillege, Hans A. Bosker, Dirk J. A. Lok, Dirk J. Van Veldhuisen, Isabelle C. Van Gelder, for the CONVERT Investigators (2008-10-15). "Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation: A Randomized Trial". JAMA 300 (15): 1784-1792. DOI:10.1001/jama.300.15.1784. Retrieved on 2008-10-15. Research Blogging.
- ↑ Sweeney MO, Bank AJ, Nsah E, et al (September 2007). "Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease". N. Engl. J. Med. 357 (10): 1000–8. DOI:10.1056/NEJMoa071880. PMID 17804844. Research Blogging.
- ↑ Saksena S, Prakash A, Ziegler P, et al (September 2002). "Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy". J. Am. Coll. Cardiol. 40 (6): 1140–50; discussion 1151–2. PMID 12354441. [e]
- ↑ Wazni OM, Marrouche NF, Martin DO, et al (June 2005). "Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial". JAMA 293 (21): 2634–40. DOI:10.1001/jama.293.21.2634. PMID 15928285. Research Blogging.
- ↑ Oral H, Pappone C, Chugh A, et al (March 2006). "Circumferential pulmonary-vein ablation for chronic atrial fibrillation". N. Engl. J. Med. 354 (9): 934–41. DOI:10.1056/NEJMoa050955. PMID 16510747. Research Blogging.
- ↑ Khan MN, Jaïs P, Cummings J, et al (October 2008). "Pulmonary-vein isolation for atrial fibrillation in patients with heart failure". N. Engl. J. Med. 359 (17): 1778–85. DOI:10.1056/NEJMoa0708234. PMID 18946063. Research Blogging.
- ↑ Hart RG, Pearce LA, Aguilar MI (2007). "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation". Ann. Intern. Med. 146 (12): 857-67. PMID 17577005. [e]
- ↑ Paciaroni M, Agnelli G, Micheli S, Caso V (2007). "Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials". Stroke 38 (2): 423-30. DOI:10.1161/01.STR.0000254600.92975.1f. PMID 17204681. Research Blogging. ACP JC synopsis
- ↑ Connolly SJ, Pogue J, Hart RG, et al. (May 2009). "Effect of clopidogrel added to aspirin in patients with atrial fibrillation". N. Engl. J. Med. 360 (20): 2066–78. DOI:10.1056/NEJMoa0901301. PMID 19336502. Research Blogging.
- ↑ 18.0 18.1 Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. (2009). "Dabigatran versus Warfarin in Patients with Atrial Fibrillation.". N Engl J Med 361 (12): 1139-1151. DOI:10.1056/NEJMoa0905561. PMID 19717844. Research Blogging.